Skip to main content

Lindsay A. Rosenwald, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Avenue Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATXI alerts

About Lindsay A. Rosenwald, M.D.

Lindsay A. Rosenwald, M.D. is recorded as Board Member at Avenue Therapeutics, Inc. (ATXI) since June 24, 2024. Avenue Therapeutics, Inc. reported in an 8-K filed June 26, 2024 that Lindsay A. Rosenwald, M.D. was appointed Director, effective June 24, 2024. Avenue Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avenue Therapeutics, Inc. includes Alexandra MacLean (CEO and Board Member), Alexandra MacLean, M.D. (CEO and Board Member), Jay Kranzler, M.D., Ph.D. (Chairman and Board Member) and 7 others.

“the election of six directors to hold office until the 2025 annual meeting of stockholders”
Avenue Therapeutics, Inc. Form 8-K, filed June 26, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Avenue Therapeutics, Inc.

Recent activity